Manufacturers Life Insurance Company, The Tarsus Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 32,929 shares of TARS stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,929
Previous 33,282
1.06%
Holding current value
$1.74 Million
Previous $904,000
19.8%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$180 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$172 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$129 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$119 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$116 Million0.01% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.4B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...